Hjem
Universitetet i Bergen
Bernt Bøgvald Aarlis bilde

Bernt Bøgvald Aarli

Førsteamanuensis
Klinisk institutt 2
Publiserte websiden kolskalkulator sammen med Bjarte Nore 1. september 2014 og vedlikeholder siden.
Vis CV
  • E-postBernt.Aarli@uib.no
  • Besøksadresse
    3 etg Sentralblokken, Lungefløyen
    Jonas Lies vei 65
    5021 BERGEN
  • Postadresse
    Postboks 7804
    5020 Bergen

The Bergen COPD Cohort Study (BergenKOLS)

The study started in 2006, and ended in 2014. More than 400 COPD patients and 300 healthy controls were included, and most were attempted followed until the end of 2014, with annual clinical examinations.

The main research question was to search for predictors of later advers outcomes such as mortality, exacerbation frequency, development of cachexia and lung function decline. Several papers are already published, and several more are underway.

Posterpresentasjoner:

 

  1. Within-day repeatability and signal to noice ratio for IOS parameters and FEV1 in smokers with and without COPD. Aarli B, Jensen R, Eagan TML, Calverley P, Bakke PS, Hardie JA. European Respiratory Sosciety Annual Congress, Vienna, September 2009.

  2. Reference values for resistance and reactance measures from Impuls Oscillometry in healthy elderly: Aarli BB, Eagan TML, Bakke PS, Hardie JA, American Thoracic Society International Conference, New Orleans, Mai 2010.

  3. Expiratory flow limitation (EFL) detected non-invasively as a phenotypic characteristic of COPD. Aarli BB, Calverley PMA, Eagan TML, Bakke PS, Hardie JA, European Respiratory Society Annual Congress, Amsterdam, September 2011.

  4. Longitudinal Variability Of Expiratory Flow Limitation (EFL) In COPD Patients And Healthy Smokers Detected Non-invasively By Impulse Oscillometry. Aarli BB, Calverley PMA , Eagan TML, Bakke PS, Hardie JA. American Thoracic Society International Conference, San Francisco, Mai 2012.

  5. Exacerbation history in COPD patients with and without expiratory flow limitation (EFL). Aarli BB, Calverley PMA , Eagan TML, Bakke PS, Hardie JA. American Thoracic Society International Conference, San Francisco, Mai 2012.

  6. Can intra-breath variations of reactance predict dyspnea?Aarli BB, Calverley PMA , Eagan TML, Bakke PS, Hardie JA. European Respiratory Society Annual Congress, Barcelona, September 2013.

  7. Mortality In COPD Patients With Increased Intrabreath Reactance, ΔXrs. Aarli BB, Calverley PMA , Eagan TML, Bakke PS, Hardie JA. American Thoracic Society International Conference, San Diego 2014.

  8. Flow limitation during resting breathing is associated with reduced exercise capability in COPD. Aarli BB, Eagan TML, Bakke PS, Hardie JA. European Respiratory Society Annual Congress, Munich, September 2014.

  9. Longitudinal changes in Peak Oxygen Uptake in Chronic Obstructive Pulmonary Disease (COPD) Patients with Dynamic Hyperinflation and/or Tidal Expiratory Flow Limitation. Aarli BB, Calverley PMA, Soler X, Powell FL, Malhotra A, Frisk B, Eagan TML, Bakke PS, Hardie JA. American Thoracic Society International Conference, San Francisco, Mai 2016.

  10. Therapeutic choices for COPD following the revised GOLD guidelines. Aarli BB, Nore KB, Garatun-Tjeldstø KY. American Thoracic Society International Conference, San Francisco, Mai 2016.

American Thoracic Society Travel Award ble tildelt for posteren: “Longitudinal Variability Of Expiratory Flow Limitation (EFL) In COPD Patients And Healthy Smokers Detected Non-invasively By Impulse Oscillometry” mai 2012.

Fulbright Fellowship og Den norske legeforenings Caroline Musæus Aarsvolds fond tildelt høst 2015 for forskningsopphold ved Division of Pulmonary, Critical Care & Sleep ved University of California San Diego. 

 

Web publikasjon:

 

www.kolskalkulator.no   Publiserte nettstedet 1. september 2014 sammen med lungelege Bjarte Nore ved Bergen legevakt og vedlikeholder siden. Et interaktivt hjelpemiddel for leger som behandler pasienter med KOLS. KOLS kalkulator prosjektet ble nominert til Forsknings- og innovasjonsprisen for helse- og omsorgstjenestene i Bergen kommune i 2016.

Medisinstudenter ved Universitet i Bergen i første, andre og fjerde termin av Indremedisin på Haukeland Universitetssjukehus og Haraldsplass Diakonale sykehus.

Vitenskapelig artikkel
  • Vis forfatter(e) (2023). Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions. Frontiers in Allergy. 11 sider.
  • Vis forfatter(e) (2022). The course and determinants of post-traumatic stress over 12 months after hospitalization for COVID-19. Frontiers in Psychiatry. 7 sider.
  • Vis forfatter(e) (2022). Eosinophilic airway diseases: basic science, clinical manifestations and future challenges. European Clinical Respiratory Journal.
  • Vis forfatter(e) (2022). Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19. European Respiratory Journal. 12 sider.
  • Vis forfatter(e) (2022). A novel concentrated, interdisciplinary group rehabilitation program for patients with chronic obstructive pulmonary disease: Protocol for a nonrandomized clinical intervention study. Journal of Medical Internet Research. 1-10.
  • Vis forfatter(e) (2021). Role of a Digital Clinical Decision-Support System in General Practitioners' Management of COPD in Norway. The International Journal of Chronic Obstructive Pulmonary Disease.
  • Vis forfatter(e) (2021). Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis. British Journal of Haematology. 542-546.
  • Vis forfatter(e) (2021). Evaluation of novel concentrated interdisciplinary group rehabilitation for patients with chronic illnesses: Protocol for a nonrandomized clinical intervention study. JMIR Research Protocols. 1-13.
  • Vis forfatter(e) (2021). COPD - do the right thing. BMC Family Practice. 17 sider.
  • Vis forfatter(e) (2020). Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Family Practice. 1-6.
  • Vis forfatter(e) (2020). NORDSTAR: paving the way for a new era in asthma research. European Respiratory Journal. 7 sider.
  • Vis forfatter(e) (2020). Effect of stimulating waveform and of data processing on respiratory impedance measurement. Physiological Measurement. 9 sider.
  • Vis forfatter(e) (2020). Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19. European Respiratory Journal.
  • Vis forfatter(e) (2017). The association of tidal EFL with exercise performance, exacerbations, and death in COPD. The International Journal of Chronic Obstructive Pulmonary Disease. 2179-2188.
  • Vis forfatter(e) (2017). Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients. PLOS ONE. 1-13.
  • Vis forfatter(e) (2015). Å være luftstrømsbegrenset i hvile. BestPractice Lungemedicin.
  • Vis forfatter(e) (2015). Variability of within-breath reactance in COPD patients and its association with dyspnoea. European Respiratory Journal. 625-634.
  • Vis forfatter(e) (2013). Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. Clinical Respiratory Journal. 245-252.
Doktorgradsavhandling
  • Vis forfatter(e) (2018). Tidal Expiratory Flow Limitation: A new method for evaluating pulmonary function in elderly and patients with Chronic Obstructive Pulmonary Disease .
Poster
  • Vis forfatter(e) (2016). Therapeutic choices for COPD following the revised GOLD guidelines.
  • Vis forfatter(e) (2016). Longitudinal changes in Peak Oxygen Uptake in Chronic Obstructive Pulmonary Disease (COPD) Patients with Dynamic Hyperinflation and/or Tidal Expiratory Flow Limitation.
  • Vis forfatter(e) (2014). Mortality In COPD Patients With Increased Intrabreath Reactance.
  • Vis forfatter(e) (2014). Flow limitation during resting breathing is associated with reduced exercise capability in COPD.
  • Vis forfatter(e) (2013). Can intra-breath variations of reactance predict dyspnea?
  • Vis forfatter(e) (2012). Longitudinal Variability Of Expiratory Flow Limitation (EFL) In COPD Patients And Healthy Smokers Detected Non-invasively By Impulse Oscillometry.
  • Vis forfatter(e) (2012). Exacebation history in COPD patients with and without expiratory flow limitation (EFL).
  • Vis forfatter(e) (2011). Expiratory flow limitation (EFL) detected non-invasively as a phenotypic characteristic of COPD.
  • Vis forfatter(e) (2010). Reference values for resistance and reactance measures from Impuls Oscillometry in healthy elderly.
  • Vis forfatter(e) (2009). Within-day repeatability and signal to noise ratio for IOS parameters and FEV1 in smokers with and without COPD.
Fagartikkel
  • Vis forfatter(e) (2022). Alvorlig astma. Indremedisineren.
  • Vis forfatter(e) (2015). Å være luftstrømsbegrenset i hvile. BestPractice. Lungemedisin.
Faglig kapittel
  • Vis forfatter(e) (2013). Utryddelse av tuberkulosen? Et tilbakeblikk over de siste 25 år. 145-154. I:
    • Vis forfatter(e) (2013). Norsk lungehelse. Norsk forening for lungemedisin.

Se fullstendig oversikt over publikasjoner i CRIStin.

 

  1. Aarli BB, Eagan TM, Ellingsen I, Bakke PS, Hardie JA. Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly, Clin Respir J. 2013 Jul;7(3):245-52. doi: 10.1111/j.1752-699X.2012.00312.x. Epub 2012 Aug 20.

  2. Aarli BB, Calverley PMA, Jensen RL, Eagan TM, Bakke PS, Hardie JA. Variability of within-breath reactance in COPD patients and its association with dyspnea. Eur Respir J. 2015 Mar;45(3):625-34. doi: 10.1183/09031936.00051214. Epub 2014 Oct 30.

  3. Heldal E, Harstad I, Aarli B. Utryddelse av tuberkulosen? Et tilbakeblikk over de siste 25 år. Norsk lungehelse. Jubileumsbok for Norsk forening for lungemedisin ved 75-årsjubileet. Side 145-154. 2012.

  4. Tuberkulose. Metodebok i akutt indremedisin 2012, Medisinsk avdeling, Hjerteavdelingeb, Lungeavdelingen, Haukeland Universitetssykehus, Side 257-258. 6. utgave, 1. opplag. Januar 2012.